STAT+: Device that uses biodegradable polymers to repair peripheral nerves gets FDA clearance
A polymer-based device cleared by the FDA offers physicians a new way for repairing peripheral nerve injuries.
A sutureless device for peripheral nerve repair could be available on the market in the coming months.
The Food and Drug Administration has authorized a polymer-based device developed by medical technology company Tissium. The authorization, announced Tuesday, will give physicians a new method for treating peripheral nerve injuries.
“This approval is really a game-changer for patients with peripheral nerve injuries,” said Jeffrey Karp, a Tissium co-founder who developed the device’s technology. “For the first time, surgeons now have a sutureless, bio-inspired option that can really simplify the procedure while improving outcomes.”
